RCM
AMPH icon

Rotella Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Rotella Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-13,012
Closed -$152K – 412
2015
Q3 		$152K Buy
+13,012
New +$195K 0.05% 365

Other funds holding AMPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rotella Capital Management's AMPH Position: Q4 2015 in Review

Rotella Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2015, closing a stake of 13,012 shares — an estimated $152K sold.

Rotella Capital Management first reported a position in AMPH in Q3 2015 and held it in 1 quarter. The position peaked at $152K in Q3 2015. 95 funds tracked by Wall St. Rank hold AMPH as of Q4 2015.

  • Rotella Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Rotella Capital Management sold 13,012 Amphastar Pharmaceuticals shares in Q4 2015, an estimated $152K.
  • Rotella Capital Management first reported a position in Amphastar Pharmaceuticals in Q3 2015 and held it in 1 quarter.
  • Rotella Capital Management's Amphastar Pharmaceuticals position peaked at $152K in Q3 2015.
  • 95 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2015.

Based on Rotella Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.